Phase I/II Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 After Oral Administration in Premature Ejaculation Patients
Phase of Trial: Phase I/II
Latest Information Update: 31 Jul 2012
At a glance
- Drugs Dapoxetine (Primary)
- Indications Premature ejaculation
- Focus Adverse reactions
- 31 Jul 2012 Actual end date May 2012 added as reported by ClinicalTrials.gov.
- 01 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov..
- 23 Aug 2011 New trial record